Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis
Clinical trial NCT01615887 · COMPLETED
Trial details
- NCT number
- NCT01615887
- Sponsor
- State University of New York at Buffalo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.